Literature DB >> 25068867

Perioperative management of tonsilloadenoidectomy and circumcision of a patient with Bernard-Soulier syndrome: case report.

Yasemin I Balci1, Ersin Gözkeser, Aziz Polat, Merve Gürses, Cüneyt O Kara, Özkan Herek.   

Abstract

Bernard-Soulier syndrome is an autosomal recessive coagulopathy characterized by thrombocytopenia, prolonged bleeding time and large platelets. Because of the rarity of this disease, standard perioperative treatment protocols have not been developed and there are not enough available data for the management of surgical procedures. In this case, we successfully performed adenoidectomy and tonsillectomy and circumcision surgery concurrently under the preventive and intermittent transfusion of platelets. During hospitalization, no intraoperative or postoperative bleeding complications occurred.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25068867     DOI: 10.1097/MBC.0000000000000175

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.

Authors:  Sara Orsini; Patrizia Noris; Loredana Bury; Paula G Heller; Cristina Santoro; Rezan A Kadir; Nora C Butta; Emanuela Falcinelli; Ana Rosa Cid; Fabrizio Fabris; Marc Fouassier; Koji Miyazaki; Maria Luisa Lozano; Pamela Zúñiga; Claire Flaujac; Gian Marco Podda; Nuria Bermejo; Remi Favier; Yvonne Henskens; Emmanuel De Maistre; Erica De Candia; Andrew D Mumford; Gul Nihal Ozdemir; Ibrahim Eker; Paquita Nurden; Sophie Bayart; Michele P Lambert; James Bussel; Barbara Zieger; Alberto Tosetto; Federica Melazzini; Ana C Glembotsky; Alessandro Pecci; Marco Cattaneo; Nicole Schlegel; Paolo Gresele
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

Review 2.  Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions.

Authors:  Robert H Lee; Raj S Kasthuri; Wolfgang Bergmeier
Journal:  Curr Opin Hematol       Date:  2020-11       Impact factor: 3.218

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.